Recombinant DNA research: the scope and limits of regulation
- PMID: 507257
- PMCID: PMC1619327
- DOI: 10.2105/ajph.69.12.1252
Recombinant DNA research: the scope and limits of regulation
Abstract
The paper provides an overview of public policy issues pertaining to the use of gene-splicing (recombinant DNA [deoxyribonucleic acid]) techniques in research and for industrial applications. Included is a discussion of the regulatory framework at the federal and institutional levels. The principal limitation of the current federal guidelines is its failure to provide mandatory coverage for private sector activities. Four municipalities and two states have passed their own legislation to remedy the situation. These enactments and their tie-in to the public health sector are examined.
Similar articles
-
Introduction to recombinant DNA research, development and evolution of the NIH guidelines, and proposed legislation.Univ Toledo Law Rev. 1981 Summer;12(4):804-14. Univ Toledo Law Rev. 1981. PMID: 11649587 No abstract available.
-
Petition to amend the National Institutes of Health Guidelines for Research Involving Recombinant DNA Molecules to establish a Public Policy Advisory Committee. Foundation on Economic Trends, September 18, 1990.Hum Gene Ther. 1991 Summer;2(2):131-4. doi: 10.1089/hum.1991.2.2-131. Hum Gene Ther. 1991. PMID: 1911933 No abstract available.
-
NIH guidelines for research involving recombinant DNA molecules.Account Res. 1993;3(2-3):177-85. doi: 10.1080/08989629308573848. Account Res. 1993. PMID: 11652293 No abstract available.
-
Controlling the bugs. The first decade in the regulation of biotechnology.Appl Biochem Biotechnol. 1985 Dec;11(6):489-506. doi: 10.1007/BF02798643. Appl Biochem Biotechnol. 1985. PMID: 3914236 Review.
-
Oversight and Review of Clinical Gene Transfer Protocols: Assessing the Role of the Recombinant DNA Advisory Committee.Washington (DC): National Academies Press (US); 2014 Mar 27. Washington (DC): National Academies Press (US); 2014 Mar 27. PMID: 24354033 Free Books & Documents. Review.
Cited by
-
Designing Oversight for Nanomedicine Research in Human Subjects: Systematic Analysis of Exceptional Oversight for Emerging Technologies.J Nanopart Res. 2011 Apr;13(4):1449-1465. doi: 10.1007/s11051-011-0237-y. J Nanopart Res. 2011. PMID: 23226969 Free PMC article.
-
Identifying biohazards in university research.Am J Public Health. 1980 Oct;70(10):1108-10. doi: 10.2105/ajph.70.10.1108. Am J Public Health. 1980. PMID: 7416332 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous